Holen Sie sich die Stockscreener-App
0.9999
4.17%
0.04
Handel nachbörslich:
1.00
0.000100
+0.01%
Schlusskurs vom Vortag:
$0.9599
Offen:
$0.9599
24-Stunden-Volumen:
157.16K
Relative Volume:
0.35
Marktkapitalisierung:
$15.08M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-11.90M
KGV:
-0.00485
EPS:
-206.0125
Netto-Cashflow:
$-12.75M
1W Leistung:
-1.00%
1M Leistung:
-1.00%
6M Leistung:
+2.03%
1J Leistung:
+570.17%
1-Tages-Spanne:
$0.9599
$0.9999
1-Wochen-Bereich:
$0.93
$1.02
52-Wochen-Spanne:
$0.1131
$3.95
Allarity Therapeutics Inc Stock (ALLR) Company Profile
Firmenname
Allarity Therapeutics Inc
Sektor
Branche
Telefon
401-426-4664
Adresse
24 SCHOOL ST., 2ND FLOOR, BOSTON
Vergleichen Sie ALLR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALLR
Allarity Therapeutics Inc
|
0.9999 | 14.47M | 0 | -11.90M | -12.75M | -206.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Allarity Therapeutics Inc Stock (ALLR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-28 | Eingeleitet | Ascendiant Capital Markets | Buy |
Allarity Therapeutics Inc Aktie (ALLR) Neueste Nachrichten
Will Allarity Therapeutics Inc. bounce back from current supportPortfolio Update Report & Free Expert Verified Stock Movement Alerts - Newser
Allarity Therapeutics Inc. stock volume spike explainedJuly 2025 Closing Moves & Weekly Market Pulse Alerts - Newser
Advanced analytics toolkit walkthrough for Allarity Therapeutics Inc.Earnings Recap Report & Low Risk Entry Point Tips - Newser
What machine learning models say about Allarity Therapeutics Inc.July 2025 Decliners & Daily Stock Trend Reports - Newser
Identifying reversal signals in Allarity Therapeutics Inc. [July 2025 Intraday Action]AI Powered Market Entry Ideas - Newser
Will Allarity Therapeutics Inc. stock benefit from interest rate changesQuarterly Portfolio Summary & Smart Swing Trading Alerts - Newser
Statistical indicators supporting Allarity Therapeutics Inc.’s strengthWeekly Trend Report & Community Trade Idea Sharing Platform - Newser
Price action breakdown for Allarity Therapeutics Inc.Smart Safety Strategy With Real Data Analysis - Newser
What MACD signals say about Allarity Therapeutics Inc.Free Early Entry Picks Before News Breakout - Newser
Published on: 2025-08-12 05:26:12 - Newser
Strategies to average down on Allarity Therapeutics Inc.Weekly Chart Watchlist with Trade Guidance - Newser
Chart overlay techniques for tracking Allarity Therapeutics Inc.Free Weekly Watchlist of High Movers - Newser
Does Allarity Therapeutics Inc. fit your quant trading modelForecast Model for Intraday Buy Signals - Newser
Is Allarity Therapeutics Inc. affected by consumer sentimentPositive Outlook Long-Term Picks - newsyoung.net
Short interest data insights for Allarity Therapeutics Inc.Oversold Opportunity Scanner with RSI Data - Newser
Custom watchlist performance reports with Allarity Therapeutics Inc.Short-Term Trade Setup with Forecast Insight - Newser
Identifying reversal signals in Allarity Therapeutics Inc.Smart Trade Mapping with Entry Details - Newser
Is Allarity Therapeutics Inc. forming a reversal patternEarly Entry Ideas with Momentum Potential - Newser
Chart based analysis of Allarity Therapeutics Inc. trendsRisk-Managed Trade Alerts for Consistency - Newser
Momentum divergence signals in Allarity Therapeutics Inc. chartReal-Time Equity Price Action Analysis - Newser
Is Allarity Therapeutics Inc. the Top Chart Pick This WeekTop Performing Stock Insights Released Daily - beatles.ru
Analyzing Allarity Therapeutics Inc. with multi timeframe chartsTriple Digit Gain Opportunity Watchlist - Newser
Order flow analysis tools used on Allarity Therapeutics Inc.Trade Safety Matrix for Conservative Traders - Newser
Allarity Therapeutics Inc. Stock Analysis and ForecastCapitalize on market momentum for profits - Jammu Links News
What makes Allarity Therapeutics Inc. stock price move sharplyPhenomenal capital appreciation - Jammu Links News
What are the technical indicators suggesting about Allarity Therapeutics Inc.Build wealth with reliable stock picks - Jammu Links News
When is Allarity Therapeutics Inc. stock expected to show significant growthFree Investment Timing Strategies - Jammu Links News
What is the dividend policy of Allarity Therapeutics Inc. stockInvest smarter with data-backed insights - Jammu Links News
What is Allarity Therapeutics Inc. company’s growth strategyUnlock powerful portfolio management tools - Jammu Links News
How volatile is Allarity Therapeutics Inc. stock compared to the marketFree Investment Timing Strategies - Jammu Links News
Should I hold or sell Allarity Therapeutics Inc. stock in 2025Exceptional stock performance - Jammu Links News
What drives Allarity Therapeutics Inc. stock priceOutstanding capital appreciation - jammulinksnews.com
What is the risk reward ratio of investing in Allarity Therapeutics Inc. stockDynamic capital growth - Jammu Links News
What are analysts’ price targets for Allarity Therapeutics Inc. in the next 12 monthsExceptional risk-adjusted gains - Jammu Links News
Will Allarity Therapeutics Inc. outperform the marketAI-Based Reversal Point Prediction Signal - Newser
Wall Street Zen Downgrades Allarity Therapeutics (NASDAQ:ALLR) to Sell - Defense World
How Allarity Therapeutics Inc. stock performs during market volatilityMulti-Year Signal Summary and Entry Timing - Newser
What institutional investors are buying Allarity Therapeutics Inc. stockRetirement Planning Review With Proven Results - Jammu Links News
Finanzdaten der Allarity Therapeutics Inc-Aktie (ALLR)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):